ArthNow Logo
ArthNow
•3 min read•
✦Reported by Firstpost

Sarvam AI faces backlash over giving access to Chinese models

Sarvam AI faces backlash over giving access to Chinese models
Source: Firstpost

Executive Brief • Key Highlights

Fast factual intelligence distilled for busy investors, executives, and answer bots:

  • ✓Sarvam AI faces backlash after its new Token Factory platform started offering access to Chinese models like DeepSeek and Moonshot AI.
  • ✓The Bengaluru-based startup previously pushed for India to build independent technology.
  • ✓Many now question this move, as the company got government support to develop domestic AI models instead.

Story at a Glance

Category
Indian Markets
Reported By
Firstpost
Reading Speed
3 Minute(s)
Market Focus
India Economy

Sarvam AI has been among the AI companies that promotes in-house chatbots and reduce dependence on foreign technology. But its latest business decision has introduced an interesting contradiction into the conversation around technological sovereignty.

The Bengaluru-based AI startup has launched Token Factory, an inference platform that gives developers and businesses access to several artificial intelligence models through a single application programming interface (API). Alongside its own models, however, the platform is also offering access to systems developed by Chinese AI companies, including DeepSeek, Moonshot AI and Z.AI.

That is an interesting development, particularly given Sarvam's positioning around India's need to build independent AI capabilities. The company has received government backing through the IndiaAI Mission and was among the early recipients of subsidised computing resources to develop domestic AI models.

🔒
Premium Content

Unlock the Full Story with ArthNow Premium

To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.

✓ Full Unabridged Reports✓ Executive Audio Briefs✓ 100% Ad-Free Reading
Verified Publication Source

Firstpost

Read the full, original unfiltered story directly on the publisher's portal.

Visit Original Article

This brief is for information only and is not investment advice. ArthNow is not a SEBI-registered investment adviser and does not publish buy or sell recommendations. Original reporting is credited to the publisher named above. Read our editorial policy or report an error.